Table 1 Demographics/tumour characteristics
ES-SBA | LS-SBA | |
|---|---|---|
N (%) = 48 | N (%) = 59 | |
Gender | ||
Male | 28 (58.3) | 31 (52.5) |
Female | 20 (41.7) | 28 (47.5) |
Age (mean & range) | 57 (28–78) | 59 (28 – 87) |
Median | 59 | 61 |
Site of Primary tumour | ||
Duodenum | 30 (62.5) | 40 (67.8) |
Jejunum | 10 (20.8) | 11 (18.6) |
Ileum | 7 (14.6) | 8 (13.6) |
Small bowel unknown | 1 (2.1) | 0 (0) |
Grade (differentiation) | ||
Low and moderate | 27 (56.3) | N/A |
Poor | 20 (41.7) | |
Missing | 1 (2.1) | |
Nodes harvested | ||
≤12 | 21 (43.8) | N/A |
>12 | 16 (33.3) | |
Missing | 11 (22.9) | |
Nodes involved (in those harvested) | N/A | |
Negative (stage I/II) | 30 (62.5) | |
Positive (Stage III) | 12 (25.0) | |
Missing | 6 (12.5) | |
LVI | ||
No | 18 (37.5) | N/A |
Yes | 22 (45.8) | |
Missing | 8 (16.7) | |
PNI | ||
No | 29 (60.4) | N/A |
Yes | 11 (22.9) | |
Missing | 8 (16.7) | |
Resection Status | ||
R0 | 44 (91.6) | N/A |
R1 | 4 (8.4) | |
Adjuvant Chemo | ||
No | 21 (44.9) | N/A |
Yes | 27 (55.1) | |
Single | 9 (18.8) | |
Multiple | 18 (37.5) | |
Disease status | ||
Locally Advanced | N/A | 5 (8.5) |
Metastatic | 54 (91.5) | |
First Line Chemo | ||
No | N/A | 13 (22.0) |
Yes | 46 (78.0) |